AI assistant
AbbVie Inc. — Director's Dealing 2014
Feb 24, 2014
29755_dirs_2014-02-24_d0758307-72de-4a6b-a0c7-1b5bf02bc19c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-20
Reporting Person: ALBAN CARLOS (EVP, Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-20 | Common stock, $0.01 par value | A | 47260 | $0.00 | Acquired | 223339 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-20 | Option (right to buy) | $51.42 | A | 81500 | Acquired | 2024-02-19 | Common stock (81500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 40442 | Indirect |
Footnotes
F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 27,167 on 02/20/2015, 27,166 on 02/20/2016, and 27,167 on 02/20/2017.